CRH Medical Corp (CRH) Price Target Cut to C$2.50 by Analysts at TD Securities
Other equities research analysts have also recently issued reports about the stock. Scotiabank cut shares of CRH Medical Corp from an outperform rating to a sector perform rating and decreased their price objective for the stock from C$10.00 to C$8.00 in a report on Friday, July 14th. Bloom Burton cut shares of CRH Medical Corp from a buy rating to an accumulate rating in a report on Friday, July 14th. National Bank Financial decreased their price objective on shares of CRH Medical Corp from C$9.00 to C$7.00 in a report on Monday, July 17th. Royal Bank Of Canada upped their price objective on shares of CRH Medical Corp from C$8.50 to C$10.00 and gave the stock a sector perform rating in a report on Monday, July 17th. Finally, Beacon Securities cut shares of CRH Medical Corp from a buy rating to a hold rating in a report on Thursday, August 3rd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of C$3.88.
Shares of CRH Medical Corp (TSE CRH) traded up C$0.09 during trading hours on Monday, hitting C$2.28. The company had a trading volume of 557,382 shares, compared to its average volume of 350,825. CRH Medical Corp has a 52 week low of C$2.15 and a 52 week high of C$12.35.
CRH Medical Corp Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.